CClinicalTrials.gg
Not yet recruitingNCT07475078Updated Mar 16, 2026

Reactive Strength and Dynamic Rebound: A Drop Jump Index Comparison

An interventional study of Drop Jump Protocol in Physical Performance Parameters, sponsored by University Institute of Maia. Not yet recruiting at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by University Institute of Maia · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The stretch-shortening cycle (SSC) is a fundamental mechanism in explosive human movement, enabling musculotendinous units to store and release elastic energy, thereby allowing the body to produce higher forces and velocities with greater mechanical efficiency. Movements such as sprinting, jumping, hopping, and sudden changes of direction, which depend on rapid force application, are supported by an effective SSC. Because of this, identifying a simple and interpretable index of SSC function has long been a priority in both research and applied sport settings.

The Reactive Strength Index (RSI), most commonly defined as the ratio of jump height to ground contact time, has become the most widely used metric for quantifying SSC performance. However, this ratio presents notable methodological limitations: it combines variables of incompatible dimensions and is insensitive to drop height, thereby ignoring the eccentric load imposed on the musculotendinous system. The Dynamic Rebound Index (DRI), recently proposed as a dimensionless and mechanically grounded alternative, is calculated as DRI = (box height + jump height) / (9.8 × ground contact time²). Despite its theoretical advantages, a direct comparison between the RSI and DRI remains unexplored in the literature, which justifies the relevance of the present study.

This study aims to compare the RSI and the DRI in physically active adults of both sexes during the execution of the Drop Jump at four different drop heights (20, 30, 40, and 50 cm). The specific objectives are: (a) to characterize performance across the four height conditions; (b) to analyze differences between sexes in both indices; (c) to examine the effect of drop height on both indices; and (d) to explore the informative complementarity between the two indices.

02

Conditions studied

  • Physical Performance Parameters
03

In context

Lead sponsor

University Institute of Maia is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18 years or older.
  • Physically active (engaging in regular physical activity at least 3 times per week - minimum of 180 min of physical activity).

Exclusion criteria

Exclusion Criteria:

  • Any musculoskeletal injuries at the time of data collection.
  • Any medical condition that could compromise physical performance or safety during testing.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Drop Jump 20 cm

    Participants perform 3 valid Drop Jump trials from a 20 cm drop height

    Other: Drop Jump Protocol

  • Experimental
    Drop Jump 30 cm

    Participants perform 3 valid Drop Jump trials from a 30 cm drop height

    Other: Drop Jump Protocol

  • Experimental
    Drop Jump 40 cm

    Participants perform 3 valid Drop Jump trials from a 40 cm drop height

    Other: Drop Jump Protocol

  • Experimental
    Drop Jump 50 cm

    Participants perform 3 valid Drop Jump trials from a 50 cm drop height

    Other: Drop Jump Protocol

Interventions

  • OtherDrop Jump Protocol

    Participants perform 3 valid Drop Jump trials at each of four drop heights (20, 30, 40, and 50 cm) in a randomized order, with 1 minute of rest between trials and 5 minutes between conditions. Jump height and ground contact time are recorded using a contact mat (ChronoJump, Boscosystem, Spain) for subsequent calculation of the RSI and DRI.

    Also known as: DJ

06

What researchers measure

Primary outcomes

  1. Reactive Strength Index (RSI)

    Calculated as RSI = jump height (m) / ground contact time (s), measured during the Drop Jump at four drop heights (20, 30, 40, and 50 cm).

    Time frame: Baseline

  2. Dynamic Rebound Index (DRI)

    Calculated as DRI = (box height (m) + jump height (m)) / (9.8 × ground contact time² (s)), measured during the Drop Jump at four drop heights (20, 30, 40, and 50 cm)

    Time frame: Baseline

Secondary outcomes

  1. Jump Height

    Vertical jump height (m) recorded via contact mat during the Drop Jump.

    Time frame: Baseline

  2. Ground Contact Time

    Time (s) spent in contact with the ground during the Drop Jump, recorded via contact mat.

    Time frame: Baseline

07

Study locations

1 site
  • University of Maia
    Maia, Porto District 4475-690 Maia, Portugal
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07475078
Lead sponsor
University Institute of Maia
Responsible party
Henrique Sousa (Principal Investigator, University Institute of Maia) — Principal investigator
First posted
Mar 16, 2026
Start date
Mar 2026 (estimated)
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Mar 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion